BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 1504216)

  • 1. [Cefuroxime axetil in the treatment of lower respiratory tract infections in patients with chronic lung diseases].
    Marcos Sánchez F; Llorente Domingo P; Celdran Gil J; Durán Pérez-Navarro A
    An Med Interna; 1992 May; 9(5):260-1. PubMed ID: 1504216
    [No Abstract]   [Full Text] [Related]  

  • 2. An assessment of the clinical efficacy in general practice of cefuroxime axetil when used in the management of unidentified infections of the lower respiratory tract.
    Wight LJ; Vandenburg MJ; Griffiths GK; Gudgeon AC; Kelsey M
    Br J Clin Pract; 1987 Nov; 41(11):991-4. PubMed ID: 3504320
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of lower respiratory tract infections with cefuroxime-axetil. Comparison with cefaclor].
    Pariente R; Rochemaure J; Murciano D; Brechot JM; Pappo M
    Therapie; 1988; 43 Suppl 4():361-4. PubMed ID: 3222777
    [No Abstract]   [Full Text] [Related]  

  • 4. [Efficacy and tolerability of cefuroxime-axetil in infections of the upper respiratory tract. Comparative study with cefadroxil].
    Dupuis G; Ebbo D; Evennou A; Pappo M
    Rev Laryngol Otol Rhinol (Bord); 1989; 110(1):123-6. PubMed ID: 2491707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of oral cefuroxime axetil and oral amoxycillin in lower respiratory tract infections.
    Cooper TJ; Ladusans E; Williams PE; Polychronopoulos V; Gaya H; Rudd RM
    J Antimicrob Chemother; 1985 Sep; 16(3):373-8. PubMed ID: 4055545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the efficacy and safety of cefuroxime axetil and augmentin in the treatment of upper respiratory tract infections.
    Hebblethwaite EM; Brown GW; Cox DM
    Drugs Exp Clin Res; 1987; 13(2):91-4. PubMed ID: 3582135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of cefuroxime axetil in clinical practice].
    Słowińska M; Szymańska E; Walecka I; Rudnicka L
    Pol Merkur Lekarski; 2000 Nov; 9(53):785-90. PubMed ID: 11204332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of cefuroxime axetil and amoxycillin in the treatment of lower respiratory tract infections.
    Spencer RC
    J Chemother; 1989 Jul; 1(4 Suppl):765-6. PubMed ID: 16312629
    [No Abstract]   [Full Text] [Related]  

  • 9. Blinded comparison of cefuroxime to cefaclor for lower respiratory tract infections.
    Schleupner CJ; Anthony WC; Tan J; File TM; Lifland P; Craig W; Vogelman B
    Arch Intern Med; 1988 Feb; 148(2):343-8. PubMed ID: 3277562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical trial of cefuroxime axetil in children.
    Carson JW; Watters K; Taylor MR; Keane CT
    J Antimicrob Chemother; 1987 Jan; 19(1):109-12. PubMed ID: 3494006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cefuroxime axetil--efficiency and safety for treatment of upper airways and middle ear infections in children].
    Barliński J
    Pol Tyg Lek; 1993 Mar 1-8; 48(9-10):233-5. PubMed ID: 8234058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of the safety and efficacy of cefuroxime axetil and cefaclor in outpatient management of community-acquired lower respiratory tract infections.
    Nolen TM; Hutchison J; Phillips HL
    J Chemother; 1989 Jul; 1(4 Suppl):768-9. PubMed ID: 16312631
    [No Abstract]   [Full Text] [Related]  

  • 13. A dose-ranging study of cefuroxime axetil in the treatment of lower respiratory tract infections in general practice.
    Spencer RC; Griggs JV; Brown GW
    Drugs Exp Clin Res; 1987; 13(2):101-3. PubMed ID: 3582133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical study of the tolerance of a new antibiotic by a pharmacovigilance cohort. Apropos of cefuroxime-axetil].
    Carbon C; Bons J; Georges D
    Therapie; 1988; 43 Suppl 4():369-72. PubMed ID: 3222779
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cefuroxime axetil. An antibiotic advances].
    Fortschr Med Suppl; 1990; 92():4-13. PubMed ID: 2199359
    [No Abstract]   [Full Text] [Related]  

  • 16. Tissue penetration following orally administered cefuroxime axetil.
    Wise R
    J Chemother; 1989 Jul; 1(4 Suppl):515-6. PubMed ID: 16312510
    [No Abstract]   [Full Text] [Related]  

  • 17. Sequential therapy with cefuroxime and cefuroxime-axetil for community-acquired lower respiratory tract infection in the oldest old.
    Flamaing J; Knockaert D; Meijers B; Verhaegen J; Peetermans WE
    Aging Clin Exp Res; 2008 Feb; 20(1):81-6. PubMed ID: 18283233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute and exacerbated chronic respiratory tract infections: treatment with a combination of cefuroxime and acetylcysteine.
    Dal Negro RW; Turco P; Zoccatelli O; Pomari C; Trevisan F
    Int J Clin Pharmacol Res; 1985; 5(5):345-50. PubMed ID: 4066085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacokinetics of cefuroxime-axetil administered by the oral route in the elderly].
    Veyssier P; Darchis JP; Devillers A
    Therapie; 1988; 43 Suppl 4():355-9. PubMed ID: 3222776
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical and pharmacokinetic comparison of cefuroxime sodium and cefuroxime lysine in the treatment of lower respiratory tract infections.
    Havard CW; Fernando A; Bannister B; Brumfitt W; Hamilton-Miller JM
    J Antimicrob Chemother; 1981 Nov; 8(5):401-8. PubMed ID: 7319981
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.